Seelos Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference

Seelos Therapeutics, Inc. (Nasdaq: SEEL) will participate in the 2021 RBC Capital Markets Global Healthcare Conference from May 18-20, 2021.

Rhea-AI Summary

Seelos Therapeutics, Inc. (Nasdaq: SEEL) will participate in the 2021 RBC Capital Markets Global Healthcare Conference from May 18-20, 2021. Chairman and CEO Raj Mehra, Ph.D., is set to present on May 18 at 4:50 PM ET and will host 1x1 meetings on May 18 and 19. The company is dedicated to developing therapies for central nervous system disorders and rare diseases, with a portfolio targeting conditions like Major Depressive Disorder, amyotrophic lateral sclerosis (ALS), and Sanfilippo syndrome. For further details, visit their website.

Argus Session date unavailable

-4.94% session move Open Argus

Details

News Market Reaction – SEEL

The recorded move for SEEL in the trading session of this news was -4.94%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, April 19, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 RBC Capital Markets Global Healthcare Conference, May 18-20, 2021.

Raj Mehra, Ph.D., Chairman and CEO, will present on Tuesday, May 18^th at 4:50pm ET and host 1x1 meetings on May 18^th and 19^th.

For more information and to register for the webcast: 2021 RBC Capital Markets Global Healthcare Conference

About Seelos Therapeutics

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare diseases. The Company's robust portfolio includes several late-stage clinical assets targeting indications including Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) or Post-Traumatic Stress Disorder (PTSD), amyotrophic lateral sclerosis (ALS), Sanfilippo syndrome, Parkinson's disease, other psychiatric and movement disorders plus orphan diseases.

For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.

Contact Information:
Anthony Marciano
Head of Corporate Communications
Seelos Therapeutics, Inc. (Nasdaq: SEEL)
300 Park Avenue
New York, NY 10022
(646) 293-2136
anthony.marciano@seelostx.com 
https://seelostherapeutics.com/ 
https://twitter.com/seelostx 
https://www.linkedin.com/company/seelos

View original content to download multimedia:http://www.prnewswire.com/news-releases/seelos-therapeutics-to-participate-in-the-2021-rbc-capital-markets-global-healthcare-conference-301270722.html

SOURCE Seelos Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Seelos Therapeutics participating in on May 18-20, 2021?

Seelos Therapeutics will participate in the 2021 RBC Capital Markets Global Healthcare Conference.

When is Raj Mehra presenting at the RBC Conference?

Raj Mehra, Ph.D., will present on Tuesday, May 18, 2021, at 4:50 PM ET.

What meetings will Seelos hold during the RBC Conference?

Seelos will host one-on-one meetings on May 18 and 19, 2021.

What is the focus of Seelos Therapeutics?

Seelos Therapeutics focuses on developing therapies for central nervous system disorders and rare diseases.

Where can I find more information about Seelos Therapeutics?

More information can be found on their website.